Connection
Michael Szarek to Skin Neoplasms
This is a "connection" page, showing publications Michael Szarek has written about Skin Neoplasms.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.104 |
|
|
|
-
Frankel AE, Woo JH, Ahn C, Pemmaraju N, Medeiros BC, Carraway HE, Frankfurt O, Forman SJ, Yang XA, Konopleva M, Garnache-Ottou F, Angelot-Delettre F, Brooks C, Szarek M, Rowinsky E. Activity of SL-401, a targeted therapy directed to interleukin-3 receptor, in blastic plasmacytoid dendritic cell neoplasm patients. Blood. 2014 Jul 17; 124(3):385-92.
Score: 0.066
-
Reynolds SR, Vergilis IJ, Szarek M, Ferrone S, Bystryn JC. Cytoplasmic melanoma-associated antigen (CYT-MAA) serum level in patients with melanoma: a potential marker of response to immunotherapy? Int J Cancer. 2006 Jul 01; 119(1):157-61.
Score: 0.038